SEC Comment Letter for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) (CIK 0001005286) (LFCR) — Feb 15, 2017
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) (CIK 0001005286)
Date: Feb. 15, 2017 · CIK: 0001005286 · Accession: 0000000000-17-005408
AI Filing Summary & Sentiment
Letter
February 15 , 2017 Mail Stop 4631 Via E -Mail Gregory S. Skinner Chief Financial Officer Landec Corporation 3603 Haven Avenue Menlo Park, CA 94025
Re: Landec Corporation Form 10 -Q for the Fiscal Quarter Ended November 27, 2016 Filed January 5, 2017 File No. 0-27446
Dear Mr. Skinner :
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
/s/ Terence O ’Brien
Show Raw Text
February 15 , 2017 Mail Stop 4631 Via E -Mail Gregory S. Skinner Chief Financial Officer Landec Corporation 3603 Haven Avenue Menlo Park, CA 94025 Re: Landec Corporation Form 10 -Q for the Fiscal Quarter Ended November 27, 2016 Filed January 5, 2017 File No. 0-27446 Dear Mr. Skinner : We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, /s/ Terence O ’Brien Terence O’Brien Accounting Branch Chief Office of Manufacturing and Construction